Label (71610 0830 30)
Amlodipine Besylate Tablet
Product Images NDC 71610-830
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 71610-830). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Aphena (Aphena)
Figure-1 (Figure1)
This text provides information on an event rate analysis for a specific treatment (Amlodipine), showing a P-value of 0.003 and a Hazard Ratio of 0.691 for the treatment group compared to placebo. The 95% confidence interval for the Hazard Ratio is provided as (0.54, 0.88). Additionally, a timeline is shown with the number at risk throughout different time points (in months).*
Figure-2 (Figure2)
This is a statistical summary of a study involving 1318 patients. The data is grouped based on age (<65 and >=65), gender (male and female), baseline sitting systolic blood pressure (SBP), baseline vessel disease, baseline vessels with stenosis, PCl-stent strata, and comparison between Amlodipine and Placebo. The study also includes hazard ratio calculations along with their confidence intervals. The average baseline SBP is 129 mmHg.*
Structure (Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
